Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2020-11-20
QLGNQualigen Therapeutics, Inc.Kruger Kurt HDirP - Purchase$3.48+6,0006,000New+$20,894
2020-11-23
BHVNBiohaven Pharmaceutical Holding Co Ltd.Childs John WDirP - Purchase$89.55+5,0002,526,9380%+$447,737
2020-11-20
ONCSOncosec Medical IncAlpha Holdings, Inc.DirS - Sale$4.92-80,0001,350,001-6%-$393,872
2020-11-19
CARACara Therapeutics, Inc.Posner ChristopherDirS - Sale$15.82-2,00011,200-15%-$31,638
M
2020-11-19
KDNYChinook Therapeutics, Inc.Dobmeier EricPres, CEOP - Purchase$13.63+2,00052,837+4%+$27,266
2020-11-23
PHASPhasebio Pharmaceuticals IncBurkhardt GlenVP, HRS - Sale$3.45-3,4970-100%-$12,065
M
2020-11-19
ARWRArrowhead Pharmaceuticals, Inc.Bradshaw CurtChief Scientific OfficerS - Sale$69.06-31,2500-100%-$2,158,125
D
2020-11-19
BMYBristol Myers Squibb CoVessey RupertEVP, Research, Early Dev.S - Sale+OE$61.30-57,59151,956-53%-$3,530,269
2020-11-19
PANDPandion Therapeutics, Inc.Becker Daniel J.DirP - Purchase$15.12+197,7162,827,883+8%+$2,989,466
2020-11-19
ALPNAlpine Immune Sciences, Inc.Conway Robert EDirP - Purchase$8.03+10,00025,000+67%+$80,300
D
2020-11-23
OLMAOlema Pharmaceuticals, Inc.Cormorant Asset Management, LPFormer 10% OwnerP - Purchase$19.00+425,0003,270,544+15%+$8,075,000
D
2020-11-23
OLMAOlema Pharmaceuticals, Inc.Graham G. WalmsleyDirP - Purchase$19.00+1,160,0001,160,000New+$22,040,000
2020-11-19
SDGRSchrodinger, Inc.Brauner ShaneSee RemarksS - Sale$57.46-5,00028,867-15%-$287,300
D
2020-11-19
SDGRSchrodinger, Inc.Tran YvonneSee RemarksS - Sale+OE$59.15-26,37727,131-49%-$1,560,256
2020-11-20
DMACDiamedica Therapeutics Inc.Giuffre Randall MichaelDirP - Purchase$4.26+15,000189,009+9%+$63,912
D
2020-11-19
EYENEyenovia, Inc.Gandolfo John PCFOP - Purchase$3.40+4,0006,000+200%+$13,600
2020-11-19
MATNMateon Therapeutics IncPark ChulhoCTOP - Purchase$0.18+22,1732,833,992+1%+$4,098
2020-11-19
MATNMateon Therapeutics IncTrieu VuongCEOP - Purchase$0.19+50,50019,944,0350%+$9,595
2020-11-19
RAPTRapt Therapeutics, Inc.Robbins WendyeDirP - Purchase$16.09+1,0005,600+22%+$16,085
D
2020-11-20
SBPHF-Star Therapeutics, Inc.Winslow GarrettGC, SecretaryS - Sale+OE$4.76-17518,575-1%-$833
D
2020-11-20
SBPHF-Star Therapeutics, Inc.Driscoll Martin JPres, CEOS - Sale+OE$4.76-17547,4250%-$833
D
2020-11-20
SBPHF-Star Therapeutics, Inc.Firmani LoriVP of Finance, TreasurerS - Sale+OE$4.76-17517,867-1%-$833
D
2020-11-20
SBPHF-Star Therapeutics, Inc.Iyer Radhakrishnan P.Chief Scientific OfficerS - Sale+OE$4.76-175137,6370%-$833
D
2020-11-20
ACADAcadia Pharmaceuticals IncStankovic Srdjan R.PresS - Sale+OE$53.50-2,72816,528-14%-$145,948
D
2020-11-18
PLXPPlx Pharma Inc.Valentino Michael JExec COBP - Purchase$3.79+264,900461,690+135%+$1,003,176
2020-11-19
ARWRArrowhead Pharmaceuticals, Inc.San Martin JavierChief Medical OfficerS - Sale$69.39-19,500130,500-13%-$1,353,105
2020-11-19
ONCSOncosec Medical IncAlpha Holdings, Inc.DirS - Sale$5.10-50,0001,430,001-3%-$255,230
2020-11-19
ZGNXZogenix, Inc.Garner Cam LDirP - Purchase$20.13+8,00056,843+16%+$161,042
2020-11-18
SPPISpectrum Pharmaceuticals IncTurgeon Joseph W.CEO, PresS - Sale$4.13-162,473530,199-23%-$671,013
M
2020-11-18
TYMETyme Technologies, Inc.Hoffman SteveCEO, 10%S - Sale$0.94-96,62125,774,9040%-$90,824
D
2020-11-18
QUREUniqure N.V.Kapusta Matthew CCEO, CFO, MDS - Sale+OE$43.69-10,313273,467-4%-$450,579
D
2020-11-19
ZTSZoetis Inc.Lagano RoxanneEVPS - Sale+OE$164.06-6,00035,680-14%-$984,360
2020-11-18
ADMPAdamis Pharmaceuticals CorpMoss Ronald B.Chief Medical OfficerS - Sale$0.41-8,532231,752-4%-$3,465
2020-11-18
ADMPAdamis Pharmaceuticals CorpHopkins Robert OCFOS - Sale$0.41-7,229289,810-2%-$2,936
2020-11-18
ADMPAdamis Pharmaceuticals CorpCarlo Dennis J PhdPres,amp; CEOS - Sale$0.41-10,665472,997-2%-$4,331
2020-11-18
ADMPAdamis Pharmaceuticals CorpDaniels Karen K.VP of OperationsS - Sale$0.41-5,333149,242-3%-$2,166
2020-11-18
ADMPAdamis Pharmaceuticals CorpMarguglio David J.SVP, Chief Business OfficerS - Sale$0.41-8,532328,148-3%-$3,465
D
2020-11-18
YMABY-Mabs Therapeutics, Inc.Gill David NDirS - Sale+OE$45.77-2,0000-100%-$91,530
DM
2020-11-18
OPTNOptinose, Inc.Mahmoud Ramy APres, COOS - Sale+OE$5.02-5,25773,465-7%-$26,366
DM
2020-11-18
OPTNOptinose, Inc.Miller Peter KCEOS - Sale+OE$5.02-5,686150,356-4%-$28,538
2020-11-19
INSMInsmed IncSharoky Melvin MdDirS - Sale$39.48-4,000254,504-2%-$157,920
D
2020-11-19
ALNYAlnylam Pharmaceuticals, Inc.Maraganore JohnCEOS - Sale+OE$124.23-34,765200,722-15%-$4,319,025
2020-11-19
RAPTRapt Therapeutics, Inc.Rieflin William JlDirP - Purchase$16.22+10,00094,722+12%+$162,200
2020-11-19
XBITXbiotech Inc.McKenzie W ThorpeDir, 10%S - Sale$18.30-375,0002,667,251-12%-$6,862,500
2020-11-19
GLSIGreenwich Lifesciences, Inc.Patel SnehalCEO, CFOP - Purchase$5.40+2,0007,779,7580%+$10,795
M
2020-11-17
PANDPandion Therapeutics, Inc.Becker Daniel J.DirP - Purchase$15.29+29,3942,630,167+1%+$449,400
D
2020-11-17
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP, GCS - Sale+OE$27.62-79,4250-100%-$2,193,446
2020-11-18
CORTCorcept Therapeutics IncBaker G Leonard JrDirP - Purchase$17.91+2,3725,155,6780%+$42,491
M
2020-11-17
SDGRSchrodinger, Inc.Shaw David E10%S - Sale$59.07-381,02610,994,668-3%-$22,507,180
M
2020-11-17
ORGOOrganogenesis Holdings Inc.Avista Capital Managing Member Iv, LLCDir, 10%P - Purchase$3.29+4,404,16229,921,676+17%+$14,500,672
DM
2020-11-17
MORFMorphic Holding, Inc.Tipirneni Praveen P.Pres, CEOS - Sale+OE$30.09-6,099645,960-1%-$183,512
D
2020-11-17
MORFMorphic Holding, Inc.Devaul WilliamGC, SecretaryS - Sale+OE$30.10-4,2753,286-57%-$128,673
2020-11-17
CARACara Therapeutics, Inc.Vogelbaum MartinDirS - Sale$16.09-6,00014,400-29%-$96,540
2020-11-17
CARACara Therapeutics, Inc.Chalmers Derek TPres, CEOS - Sale$16.00-11,799941,421-1%-$188,784
2020-11-17
ORGOOrganogenesis Holdings Inc.Katz Michael W10%P - Purchase$3.25+20,82934,432+153%+$67,694
D
2020-11-17
SDGRSchrodinger, Inc.D'Cruz ConySee RemarksS - Sale+OE$60.69-6,375171,082-4%-$386,899
2020-11-17
ORGOOrganogenesis Holdings Inc.Mackie Wayne DDirP - Purchase$3.25+42,726161,290+36%+$138,860
2020-11-17
ORGOOrganogenesis Holdings Inc.Leibowitz Arthur SDirP - Purchase$3.25+6,94330,507+29%+$22,565
D
2020-11-17
MYOVMyovant Sciences Ltd.Karbe FrankPrincipal Fin'l, AccountingS - Sale+OE$20.00-750163,4700%-$15,000
D
2020-11-17
MYOVMyovant Sciences Ltd.Arjona Ferreira Juan CamiloChief Medical OfficerS - Sale+OE$20.00-7,000138,026-5%-$140,000
2020-11-18
ONCSOncosec Medical IncAlpha Holdings, Inc.DirS - Sale$5.24-50,9992,971,001-2%-$267,316
2020-11-17
ORGOOrganogenesis Holdings Inc.Nussdorf Glenn HDir, 10%P - Purchase$3.25+833,153137,242,799+1%+$2,707,747
2020-11-18
GTHXG1 Therapeutics, Inc.Muir Glenn PDirP - Purchase$13.50+50,000170,969+41%+$675,000
2020-11-17
KROSKeros Therapeutics, Inc.Nussbaum RanDir, 10%P - Purchase$50.00+60,000155,262+63%+$3,000,000
2020-11-17
KROSKeros Therapeutics, Inc.Kariv TomerDir, 10%P - Purchase$50.00+60,000155,262+63%+$3,000,000
2020-11-17
KROSKeros Therapeutics, Inc.Pontifax Management 4 G.P. (2015) Ltd.10%P - Purchase$50.00+60,000155,262+63%+$3,000,000
2020-11-16
DFFNDiffusion Pharmaceuticals Inc.Cobuzzi Robert Joseph Jr.Pres, CEOP - Purchase$0.66+14,00014,000New+$9,240
D
2020-11-16
BBIOBridgebio Pharma, Inc.Henderson Michael ThomasChief Business OfficerS - Sale+OE$45.00-10,000274,211-4%-$450,000
2020-11-16
NKTRNektar TherapeuticsZalevsky JonathanChief R, D OfficerS - Sale$16.93-29,618266,697-10%-$501,433
2020-11-16
NKTRNektar TherapeuticsWilson Mark AndrewSVP, GCS - Sale$16.93-1,53949,850-3%-$26,055
2020-11-16
NKTRNektar TherapeuticsThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$16.93-11,976159,757-7%-$202,754
2020-11-16
TYMETyme Technologies, Inc.Demurjian Michael10%S - Sale$0.93-20,00025,118,5460%-$18,696
2020-11-16
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale$16.93-11,975352,453-3%-$202,737
2020-11-16
NKTRNektar TherapeuticsLabrucherie Gil MSVP, COO, CFOS - Sale$16.93-8,276226,973-4%-$140,113
M
2020-11-16
TZACTenzing Acquisition Corp.Glazer Capital, LLC10%S - Sale$10.90-1,328648,6660%-$14,475
D
2020-11-17
BCELAtreca, Inc.Greenberg Norman MichaelChief Scientific OfficerS - Sale+OE$15.04-1,8250-100%-$27,448
2020-11-17
EVFMEvofem Biosciences, Inc.File Justin J.CFOP - Purchase$2.17+7,760258,168+3%+$16,839
2020-11-17
EVFMEvofem Biosciences, Inc.Fitzpatrick Alexander AGC, SecretaryP - Purchase$2.20+9,090143,542+7%+$19,998
2020-11-17
ZGNXZogenix, Inc.Tannenbaum Renee PDirS - Sale$20.74-15,00032,872-31%-$311,066
D
2020-11-16
ABBVAbbvie Inc.Alban CarlosVice COBS - Sale+OE$100.00-115,830155,341-43%-$11,583,000
M
2020-11-16
SYRSSyros Pharmaceuticals, Inc.Young Richard ADirS - Sale$8.77-5,990339,211-2%-$52,558
D
2020-11-16
BPMCBlueprint Medicines CorpHaviland KateCOOS - Sale+OE$100.27-40942,838-1%-$41,010
D
2020-11-16
BPMCBlueprint Medicines CorpAlbers Jeffrey W.CEO, PresS - Sale+OE$98.71-20,000141,434-12%-$1,974,295
D
2020-11-16
BPMCBlueprint Medicines CorpHurley ArielPrincipal Accounting OfficerS - Sale+OE$100.92-1,7009,984-15%-$171,564
DM
2020-11-16
RETAReata Pharmaceuticals IncMeyer Colin JohnChief Research OfficerS - Sale+OE$169.57-25,00072,000-26%-$4,239,148
2020-11-16
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, Chief Patient OfficerS - Sale$223.53-4249,9870%-$9,388
2020-11-16
VRTXVertex Pharmaceuticals Inc / MaParini MichaelEVP, Chief Adm, Leg, BD OffS - Sale$223.53-9126,8380%-$20,341
2020-11-16
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP, Chief Commercial OfficerS - Sale$223.64-735,3190%-$1,565
2020-11-16
RGLSRegulus Therapeutics Inc.Aker Christopher RaySVP, GCS - Sale$0.52-87625,762-3%-$456
2020-11-16
MNKKQMallinckrodt PlcO'Neill Hugh M.EVP, Chief Comm , Ops OfcrS - Sale$0.13-75078,956-1%-$94
2020-11-16
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$223.47-3828,9020%-$8,492
2020-11-16
RGLSRegulus Therapeutics Inc.Hagan Joseph PPres, CEOS - Sale$0.52-6,094215,994-3%-$3,176
D
2020-11-17
REGNRegeneron Pharmaceuticals, Inc.Murphy Andrew JEVP ResearchS - Sale+OE$542.73-6,62851,378-11%-$3,597,188
D
2020-11-16
ETNB89Bio, Inc.Le-Nguyen QuocSee RemarksS - Sale+OE$28.11-4,5480-100%-$127,844
D
2020-11-16
ETNB89Bio, Inc.Waisbourd RamCOO, Chief Business OfficerS - Sale+OE$27.39-7,0000-100%-$191,730
D
2020-11-16
RAPTRapt Therapeutics, Inc.Ho WilliamChief Medical OfficerS - Sale+OE$20.25-1,00071,414-1%-$20,250
D
2020-11-16
RAPTRapt Therapeutics, Inc.Brockstedt Dirk G.Chief Scientific OfficerS - Sale+OE$17.01-9,87710,256-49%-$168,008
M
2020-11-16
ONCSOncosec Medical IncAlpha Holdings, Inc.DirS - Sale$5.29-80,0001,531,000-5%-$423,072
M
2020-11-16
DFFNDiffusion Pharmaceuticals Inc.Elder William RobertGC, SecretaryP - Purchase$0.66+15,00015,000New+$9,850
DM
2020-11-13
GWPHGw Pharmaceuticals PlcGover Justin D.CEOS - Sale+OE$10.02-108,492456,053-19%-$1,087,087
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top